Stock listing
Tradegate:5DT Entera Bio Ltd. Aktie
German listing (Tradegate) of Entera Bio Ltd. · home listing NASDAQ:ENTX
Follow Entera Bio Ltd. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ENTX
$2.94 USD +0.26 (+9.7%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ENTX
- Day range
- $2.62 – $2.97 USDOct 19, 2026
- Volume
- 953,136 sharesOct 19, 2026
- Market value
- $511.1M USDAt the close on Oct 19, 2026 · price × 173.8M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENTX · Home | $2.94 USD | +0.26 (+9.7%) | 953,136 | $2.66 | $2.97 | $2.62 | $2.68 | Close on Oct 19, 2026 |
| Frankfurt:5DT | €2.32 EUR | -0.06 (-2.5%) | — | €2.32 | €2.32 | €2.32 | €2.38 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:ENTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.94 | +0.26 | +9.7% | $2.66 | $2.97 | $2.62 | 953,136 | |
| $2.68 | -0.09 | -3.2% | $2.72 | $2.75 | $2.62 | 572,889 | |
| $2.77 | +0.27 | +10.8% | $2.49 | $2.82 | $2.49 | 1,447,785 | |
| $2.50 | +0.01 | +0.4% | $2.47 | $2.565 | $2.46 | 784,486 | |
| $2.49 | -0.16 | -6.0% | $2.65 | $2.65 | $2.435 | 755,300 | |
| $2.65 | -0.01 | -0.4% | $2.66 | $2.775 | $2.639 | 305,688 | |
| $2.66 | +0.16 | +6.4% | $2.51 | $2.72 | $2.505 | 1,584,092 | |
| $2.50 | -0.01 | -0.4% | $2.48 | $2.52 | $2.45 | 421,033 | |
| $2.51 | -0.02 | -0.8% | $2.52 | $2.58 | $2.45 | 679,477 | |
| $2.53 | -0.09 | -3.4% | $2.66 | $2.67 | $2.53 | 621,167 | |
| $2.62 | -0.24 | -8.4% | $2.89 | $2.89 | $2.62 | 1,254,986 | |
| $2.86 | -0.03 | -1.0% | $2.89 | $2.90 | $2.82 | 100,700 | |
| $2.89 | -0.02 | -0.7% | $2.89 | $3.00 | $2.81 | 640,880 | |
| $2.91 | +0.22 | +8.2% | $2.67 | $2.975 | $2.57 | 520,976 | |
| $2.69 | 0.00 | 0.0% | $2.70 | $2.72 | $2.66 | 160,845 | |
| $2.69 | -0.055 | -2.0% | $2.80 | $2.89 | $2.645 | 340,910 | |
| $2.745 | -0.055 | -2.0% | $2.91 | $2.91 | $2.70 | 776,301 | |
| $2.80 | -0.01 | -0.4% | $2.78 | $2.88 | $2.71 | 234,000 | |
| $2.81 | -0.17 | -5.7% | $3.01 | $3.01 | $2.70 | 858,157 | |
| $2.98 | +0.02 | +0.7% | $3.02 | $3.03 | $2.945 | 613,718 | |
| $2.96 | 0.00 | 0.0% | $2.93 | $2.97 | $2.86 | 294,685 | |
| $2.96 | -0.07 | -2.3% | $3.14 | $3.14 | $2.88 | 288,975 | |
| $3.03 | +0.07 | +2.4% | $2.95 | $3.05 | $2.94 | 310,173 | |
| $2.96 | +0.10 | +3.5% | $2.86 | $3.05 | $2.785 | 777,611 | |
| $2.86 | +0.04 | +1.4% | $2.77 | $2.86 | $2.68 | 391,364 | |
| $2.82 | -0.02 | -0.7% | $2.81 | $2.90 | $2.76 | 100,044 | |
| $2.84 | +0.05 | +1.8% | $2.85 | $2.94 | $2.825 | 187,608 | |
| $2.79 | -0.05 | -1.8% | $2.82 | $2.85 | $2.72 | 437,618 | |
| $2.84 | -0.17 | -5.6% | $2.99 | $3.04 | $2.83 | 622,167 | |
| $3.01 | +0.01 | +0.3% | $2.95 | $3.07 | $2.82 | 824,636 | |
| $3.00 | +0.05 | +1.7% | $2.95 | $3.15 | $2.88 | 606,922 | |
| $2.95 | +0.03 | +1.0% | $2.99 | $3.025 | $2.90 | 154,038 | |
| $2.92 | +0.02 | +0.7% | $2.90 | $3.00 | $2.84 | 143,497 | |
| $2.90 | -0.05 | -1.7% | $2.94 | $3.09 | $2.80 | 256,682 | |
| $2.95 | -0.08 | -2.6% | $3.03 | $3.09 | $2.915 | 214,454 | |
| $3.03 | -0.05 | -1.6% | $3.12 | $3.15 | $3.00 | 138,183 | |
| $3.08 | -0.11 | -3.4% | $3.20 | $3.41 | $3.03 | 240,676 | |
| $3.19 | -0.28 | -8.1% | $3.46 | $3.47 | $3.10 | 523,310 | |
| $3.47 | +0.05 | +1.5% | $3.42 | $3.56 | $3.405 | 429,970 | |
| $3.42 | +0.19 | +5.9% | $3.28 | $3.47 | $3.20 | 258,132 | |
| $3.23 | +0.01 | +0.3% | $3.22 | $3.34 | $3.14 | 441,300 | |
| $3.22 | +0.11 | +3.5% | $3.01 | $3.33 | $3.00 | 468,467 | |
| $3.11 | +0.22 | +7.6% | $2.93 | $3.21 | $2.88 | 696,061 | |
| $2.89 | -0.01 | -0.3% | $2.89 | $2.969 | $2.81 | 261,718 | |
| $2.90 | +0.01 | +0.3% | $2.83 | $2.97 | $2.82 | 305,878 | |
| $2.89 | +0.02 | +0.7% | $2.85 | $2.92 | $2.75 | 278,331 | |
| $2.87 | +0.07 | +2.5% | $2.78 | $2.92 | $2.76 | 246,482 | |
| $2.80 | -0.20 | -6.7% | $3.03 | $3.03 | $2.75 | 410,047 | |
| $3.00 | -0.04 | -1.3% | $2.98 | $3.059 | $2.754 | 487,985 | |
| $3.04 | +0.17 | +5.9% | $2.83 | $3.10 | $2.66 | 727,310 | |
| $2.87 | +0.05 | +1.8% | $2.80 | $2.97 | $2.80 | 244,945 | |
| $2.82 | +0.01 | +0.4% | $2.79 | $2.99 | $2.725 | 387,932 | |
| $2.81 | -0.06 | -2.1% | $2.84 | $2.84 | $2.70 | 308,518 | |
| $2.87 | -0.09 | -3.0% | $2.93 | $2.99 | $2.74 | 841,548 | |
| $2.96 | -0.03 | -1.0% | $2.91 | $3.05 | $2.76 | 1,102,424 | |
| $2.99 | +0.04 | +1.4% | $2.95 | $3.20 | $2.92 | 1,059,800 | |
| $2.95 | -0.05 | -1.7% | $3.06 | $3.06 | $2.661 | 1,392,853 | |
| $3.00 | -0.26 | -8.0% | $3.26 | $3.369 | $2.95 | 1,581,621 | |
| $3.26 | -0.66 | -16.8% | $3.90 | $3.963 | $3.02 | 5,323,111 | |
| $3.92 | +1.87 | +91.2% | $2.96 | $4.20 | $2.77 | 83,383,914 | |
| $2.05 | -0.08 | -3.8% | $2.13 | $2.17 | $2.00 | 163,475 | |
| $2.13 | +0.10 | +4.9% | $2.012 | $2.18 | $1.991 | 291,312 | |
| $2.03 | +0.07 | +3.6% | $1.96 | $2.083 | $1.96 | 169,175 | |
| $1.96 | -0.03 | -1.5% | $1.99 | $2.02 | $1.91 | 85,170 | |
| $1.99 | +0.01 | +0.5% | $1.97 | $2.02 | $1.85 | 234,654 |
- Ticker
- Tradegate:5DT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Calls
Replays
Entera Bio (NASDAQ:ENTX) Q1 2022 Earnings Call
Wed, May 18, 2022 · 8:00 AM ET
Watch TranscriptEntera Bio (NASDAQ:ENTX) Q4 2021 Earnings Call
Tue, Mar 08, 2022 · 8:30 AM ET
Watch TranscriptEntera Bio (NASDAQ:ENTX) Q2 2021 Earnings Call
Mon, Aug 16, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
Oct 13, 2026
Closed $2.49 (-6.0%) on Oct 13, 2026
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
Oct 8, 2026
Closed $2.50 (-0.4%) on Oct 8, 2026
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Oct 6, 2026
Closed $2.53 (-3.4%) on Oct 6, 2026
Correction: Entera to Participate in Upcoming Fall Investor Conferences
Aug 27, 2026
Closed $3.08 (-3.4%) on Aug 27, 2026
Entera to Participate in Upcoming Fall Investor Conferences
Aug 27, 2026
Closed $3.08 (-3.4%) on Aug 27, 2026
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
Aug 18, 2026
Closed $2.89 (-0.3%) on Aug 18, 2026
Entera Announces Second Quarter 2026 Financial Results and Business Updates
Aug 7, 2026
Closed $3.04 (+5.9%) on Aug 10, 2026
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
Aug 4, 2026
Closed $2.87 (-3.0%) on Aug 4, 2026
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
Jul 31, 2026
Closed $2.96 (-1.0%) on Aug 3, 2026
Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE
Jul 29, 2026
Closed $3.00 (-8.0%) on Jul 29, 2026
Financings
Private placement of ordinary shares and pre-funded warrants
Aug 7, 2026
Closed: US$275M raised · US$2.04 a share · Leerink Partners +5
Dealers: Leerink Partners (lead), Evercore ISI, Guggenheim Securities, Cantor, LifeSci Capital, Canaccord Genuity
Buyers: BVF Partners L.P. (led the private placement; granted the right to designate two directors); Longitude Capital; Vivo Capital; TCGX; Spruce Street Capital; Venrock Healthcare Capital Partners; RA Capital Management; Perceptive Advisors; Driehaus Capital Management; Logos Capital; Catalio Capital Management
Use of proceeds: Fund EB613 Phase 3 program through NDA submission, advance EB612 into the clinic with OPKO, and extend cash runway into 2030
Decks
Technical Presentation (September 2025)
Technical · 19 slides · September 2025
Technical Presentation (July 2025)
Technical · 14 slides · July 2025
Investor Presentation (March 2023)
Investor deck · 33 slides · March 2023
Investor Presentation (November 2022)
Investor deck · 34 slides · November 2022
Entera Bio Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 32 in the last 12 months · 141 in all · newest Oct 13, 2026 · oldest 2019
- Calls
- 5 calls with a replay · 5 with a transcript · latest May 18, 2022
- Decks
- 9 decks · latest September 2025
Where Entera Bio Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENTX · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2JQXP | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JQXP | Lang & Schwarz | Germany | EUR |
| Stuttgart:5DT | Stuttgart | Germany | EUR |
| BOATS:ENTX | BOATS | United States | USD |
| Tradegate:5DT · This page | Tradegate | Germany | EUR |
| Dusseldorf:5DT | Dusseldorf | Germany | EUR |
| Frankfurt:5DT | Frankfurt | Germany | EUR |
| Hamburg:5DT | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about Entera Bio Ltd.